Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Ituran Location and Control
ITRN
$1.09B
| $121K | ﹤0.01% |
5,195
+4,732
| +1,022% | +$107K |
|
3352
Summit Therapeutics
SMMT
$10.4B
| $121K | ﹤0.01% |
48,272
-198,192
| -80% | -$362K |
|
3353
Hurco Companies Inc
HURC
$135M
| $121K | ﹤0.01% |
5,577
-2,119
| -28% | -$48K |
|
3354
Codexis
CDXS
$151M
| $120K | ﹤0.01% |
42,766
-17,691
| -29% | -$57.2K |
|
|
AMRS
3355
DELISTED
Amyris Inc.
AMRS
| $119K | ﹤0.01% |
115,227
-13,280
| -10% | -$12.4K |
|
|
HEPS
3356
D-Market Electronic Services & Trading
HEPS
$1.05B
| $118K | ﹤0.01% |
70,000
| – | – |
|
3357
Arrow Financial
AROW
$659M
| $117K | ﹤0.01% |
5,974
-1,417
| -19% | -$29K |
|
3358
Symbotic
SYM
$5.48B
| $116K | ﹤0.01% |
2,710
+2,706
| +67,650% | +$88.9K |
|
3359
KraneShares Global Carbon Strategy ETF
KRBN
$140M
| $116K | ﹤0.01% |
3,053
| – | – |
|
3360
Evolus
EOLS
$385M
| $116K | ﹤0.01% |
15,905
-2,065
| -11% | -$17.8K |
|
3361
Prime Medicine
PRME
$527M
| $115K | ﹤0.01% |
7,879
+2,543
| +48% | +$35.5K |
|
3362
Skyward Specialty Insurance
SKWD
$2.43B
| $115K | ﹤0.01% |
4,541
-4,026
| -47% | -$93K |
|
3363
FTAI Infrastructure
FIP
$441M
| $115K | ﹤0.01% |
31,156
-176,308
| -85% | -$572K |
|
|
FRGI
3364
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $114K | ﹤0.01% |
14,341
+3,571
| +33% | +$28.3K |
|
3365
iShares US Healthcare Providers ETF
IHF
$1.21B
| $114K | ﹤0.01% |
+2,225
| New | +$112K |
|
3366
Brown-Forman Class A
BF.A
$13.4B
| $113K | ﹤0.01% |
1,653
-2,605
| -61% | -$170K |
|
|
STER
3367
DELISTED
Sterling Check Corp. Common Stock
STER
| $112K | ﹤0.01% |
9,176
-2,794
| -23% | -$33.5K |
|
3368
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $112K | ﹤0.01% |
+2,385
| New | +$103K |
|
|
TSP
3369
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $111K | ﹤0.01% |
67,157
-15,315
| -19% | -$24.8K |
|
3370
Eagle Bancorp Montana
EBMT
$187M
| $111K | ﹤0.01% |
8,402
| – | – |
|
|
CMAX
3371
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $111K | ﹤0.01% |
1,189
-480
| -29% | -$42.3K |
|
3372
Arbutus Biopharma
ABUS
$857M
| $110K | ﹤0.01% |
47,895
-9,663
| -17% | -$25.2K |
|
3373
Brookfield
BN
$104B
| $110K | ﹤0.01% |
4,901
-97,336
| -95% | -$2.06M |
|
3374
Blue Owl Capital
OBDC
$5.34B
| $109K | ﹤0.01% |
8,154
+5,616
| +221% | +$73.4K |
|
3375
Ocular Therapeutix
OCUL
$1.79B
| $109K | ﹤0.01% |
21,123
-258,564
| -92% | -$1.54M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.